drugset / Trial / NCT06235424

Del Nido Versus HTK Cardioplegia in Adult Aortic Valve Replacement

NCT06235424 ↗

Phase 4 Unknown 100 enrolled Medical University of Gdansk
RandomizedParallel-groupSingle-blindTreatment

Summary

The goal of this clinical trial is to compare del Nido and Bretschneider-HTK (HTK) cardioplegia solutions in patients undergoing elective aortic valve replacement. The main question it aims to answer is: • Does the del Nido cardioplegia provide better cardioprotection and clinical outcomes than HTK cardioplegia? Participants will receive one of the investigated cardioplegia solutions according to the randomization. Researchers will compare both groups in terms of cardioprotection (described as levels of CK-MB and hsTnI), in-hospital clinical outcomes, biochemical changes in coronary sinus blood and one-year follow-up.

Timeline

Start
2018-10-01
Primary completion
2023-04-24
Completion
2024-09-24

Drugs

EvaluationDrugModalityDoseRoute
Comparator Del Nido Cardioplegia Solution Unknown 1000 ml —
Comparator HTK solution Unknown 20 unknown —